Paddy McDermott
President chez Transitions Optical, Inc.
Profil
Paddy McDermott has held director positions in the National Society to Prevent Blindness, Mirai Medical Ltd., and was the President & Director of Transitions Optical, Inc. Currently, he holds director positions in the National Society to Prevent Blindness, Transitions Optical, Inc., and Mirai Medical Ltd.
Postes actifs de Paddy McDermott
| Sociétés | Poste | Début |
|---|---|---|
Transitions Optical, Inc.
 Transitions Optical, Inc. Electronic ComponentsElectronic Technology Transitions Optical, Inc. manufactures photochromic ophthalmic lenses. It offers its products through eye care professionals and retail locations. The firm offers eyeglass lenses and sunglasses and shields. The company was founded in 1990 and is headquartered in Pinellas Park, FL. | President | - |
National Society to Prevent Blindness
 National Society to Prevent Blindness Miscellaneous Commercial ServicesCommercial Services National Society to Prevent Blindness operates as an eye health and safety organization. It offers services for amblyopia, AMD, cataract, central retinal vein occlusion, colour blindness, conjunctivitis, diabetic eye disease and macular enema, dry eye, floaters, glaucoma, refractive eye, retinal tears and detachments, retinitis pigments and strabismus. The company was founded in 1908 and is headquartered in Chicago, IL. | Directeur/Membre du Conseil | - |
Mirai Medical Ltd.
 Mirai Medical Ltd. Information Technology ServicesTechnology Services Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Transitions Optical, Inc.
Transitions Optical, Inc. Electronic ComponentsElectronic Technology Transitions Optical, Inc. manufactures photochromic ophthalmic lenses. It offers its products through eye care professionals and retail locations. The firm offers eyeglass lenses and sunglasses and shields. The company was founded in 1990 and is headquartered in Pinellas Park, FL. | Electronic Technology |
National Society to Prevent Blindness
National Society to Prevent Blindness Miscellaneous Commercial ServicesCommercial Services National Society to Prevent Blindness operates as an eye health and safety organization. It offers services for amblyopia, AMD, cataract, central retinal vein occlusion, colour blindness, conjunctivitis, diabetic eye disease and macular enema, dry eye, floaters, glaucoma, refractive eye, retinal tears and detachments, retinitis pigments and strabismus. The company was founded in 1908 and is headquartered in Chicago, IL. | Commercial Services |
Mirai Medical Ltd.
Mirai Medical Ltd. Information Technology ServicesTechnology Services Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then. | Technology Services |
